These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
247 related items for PubMed ID: 30577197
1. Adherence of Renal Transplant Recipients to Once-daily, Prolonged-Release and Twice-daily, Immediate-release Tacrolimus-based Regimens in a Real-life Setting in Sweden. Fellström B, Holmdahl J, Sundvall N, Cockburn E, Kilany S, Wennberg L. Transplant Proc; 2018 Dec; 50(10):3275-3282. PubMed ID: 30577197 [Abstract] [Full Text] [Related]
6. Renal Function and Patient-Reported Outcomes in Stable Kidney Transplant Patients Following Conversion From Twice-Daily Immediate-Release Tacrolimus to Once-Daily Prolonged-Release Tacrolimus: A 12-Month Observational Study in Routine Clinical Practice in Germany (ADAGIO). Hugo C, Weihprecht H, Banas B, Schröppel B, Jank S, Arns W, Schenker P, Rath T, Hergesell O, Feldkamp T, Hermann B, Schiffer M. Transplant Proc; 2021 Jun; 53(5):1484-1493. PubMed ID: 33610306 [Abstract] [Full Text] [Related]
7. Safety and Effectiveness of Conversion From Cyclosporine to Once-Daily Prolonged-Release Tacrolimus in Stable Kidney Transplant Patients: A Multicenter Observational Study in Japan. Usuki S, Uno S, Sugamori H, Tanaka H, Aikawa A. Transplant Proc; 2018 Dec; 50(10):3266-3274. PubMed ID: 30577196 [Abstract] [Full Text] [Related]
9. Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation. Doesch AO, Mueller S, Akyol C, Erbel C, Frankenstein L, Ruhparwar A, Ehlermann P, Dengler TJ, Katus HA. Drug Des Devel Ther; 2013 Dec; 7():1253-8. PubMed ID: 24174870 [Abstract] [Full Text] [Related]
13. A UK analysis of the cost of switching renal transplant patients from an immediate-release to a prolonged-release formulation of tacrolimus based on differences in trough concentration variability. Muduma G, Odeyemi I, Pollock RF. J Med Econ; 2014 Jul; 17(7):520-6. PubMed ID: 24754700 [Abstract] [Full Text] [Related]
14. Randomized, Open-Label, Phase IV, Korean Study of Kidney Transplant Patients Converting From Cyclosporine to Prolonged-Release Tacrolimus Plus Standard- or Reduced-Dose Corticosteroids. Baek CH, Kim CD, Lee DR, Kim YH, Yang J, Kim BS, Lee JS, Han SY, Kim SW, Lee S, Lee KW, Kong JM, Shin BC, Lee SH, Chae DW, Kwon YJ, Jiang H, Lee H, Park SK. Transplant Proc; 2019 Apr; 51(3):749-760. PubMed ID: 30979460 [Abstract] [Full Text] [Related]
15. Comparative pharmacokinetics of tacrolimus in stable pediatric allograft recipients converted from immediate-release tacrolimus to prolonged-release tacrolimus formulation. Rubik J, Debray D, Iserin F, Vondrak K, Sellier-Leclerc AL, Kelly D, Czubkowski P, Webb NJA, Riva S, D'Antiga L, Marks SD, Rivet C, Tönshoff B, Kazeem G, Undre N. Pediatr Transplant; 2019 Jun; 23(4):e13391. PubMed ID: 30932313 [Abstract] [Full Text] [Related]
16. Impact of Switching From Immediate- or Prolonged-Release to Once-Daily Extended-Release Tacrolimus (LCPT) on Tremor in Stable Kidney Transplant Recipients: The Observational ELIT Study. Giral M, Grimbert P, Morin B, Bouvier N, Buchler M, Dantal J, Garrigue V, Bertrand D, Kamar N, Malvezzi P, Moreau K, Athea Y, Le Meur Y. Transpl Int; 2024 Jun; 37():11571. PubMed ID: 38694490 [Abstract] [Full Text] [Related]